Pco371    (DrugBank: PCO-371)

1 disease
IDDisease name (Link within this page)Number of trials
235Hypoparathyroidism1

235. Hypoparathyroidism    [ 67 clinical trials,   112 drugs,   (DrugBank: 24 drugs),   4 drug target genes,   5 drug target pathways]
Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 67 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04209179
(ClinicalTrials.gov)
July 23, 202028/11/2019A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With HypoparathyroidismA Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With HypoparathyroidismHypoparathyroidismDrug: PCO371;Drug: PlaceboChugai PharmaceuticalNULLRecruiting18 YearsN/AAll24Phase 1United States;Canada;Hungary